Literature DB >> 12045720

Magnetic resonance spectroscopy in multiple sclerosis: window into the diseased brain.

Jerry S Wolinsky1, Ponnada A Narayana.   

Abstract

Magnetic resonance spectroscopy provides noninvasive insight into the regional and global biochemical alterations that are concomitants of the dynamic processes that underlie the evolution of fundamental pathologic changes in multiple sclerosis. These include now well-recognized alterations of neuronal biochemical markers that accompany tissue destruction readily visualized by magnetic resonance imaging, but also dynamic changes in several metabolites that indicate pathological processes that precede the magnetic resonance imaging-defined lesion, or completely escape current high-resolution imaging.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12045720     DOI： 10.1097/00019052-200206000-00004

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN： 1350-7540            Impact factor:   5.710


  11 in total

1.  Longitudinal whole-brain N-acetylaspartate concentration in healthy adults.

Authors:  D J Rigotti; I I Kirov; B Djavadi; N Perry; J S Babb; O Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-21       Impact factor: 3.825

Review 2.  Imaging of multiple sclerosis: role in neurotherapeutics.

Authors:  Rohit Bakshi; Alireza Minagar; Zeenat Jaisani; Jerry S Wolinsky
Journal:  NeuroRx       Date:  2005-04

Review 3.  Magnetic resonance spectroscopy in the monitoring of multiple sclerosis.

Authors:  Ponnada A Narayana
Journal:  J Neuroimaging       Date:  2005       Impact factor: 2.486

Review 4.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

Review 5.  Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder.

Authors:  Robert W Van Boven; Greg S Harrington; David B Hackney; Andreas Ebel; Grant Gauger; J Douglas Bremner; Mark D'Esposito; John A Detre; E Mark Haacke; Clifford R Jack; William J Jagust; Denis Le Bihan; Chester A Mathis; Susanne Mueller; Pratik Mukherjee; Norbert Schuff; Anthony Chen; Michael W Weiner
Journal:  J Rehabil Res Dev       Date:  2009

Review 6.  Magnetic resonance imaging biomarkers in patients with progressive ataxia: current status and future direction.

Authors:  Stuart Currie; Marios Hadjivassiliou; Ian J Craven; Iain D Wilkinson; Paul D Griffiths; Nigel Hoggard
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

Review 7.  Proton magnetic resonance spectroscopy in multiple sclerosis.

Authors:  Balasrinivasa R Sajja; Jerry S Wolinsky; Ponnada A Narayana
Journal:  Neuroimaging Clin N Am       Date:  2009-02       Impact factor: 2.264

8.  New imaging techniques in the diagnosis of multiple sclerosis.

Authors:  Yan Fu; Thomas M Talavage; Ji-Xin Cheng
Journal:  Expert Opin Med Diagn       Date:  2008-09

9.  Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).

Authors:  Ruth Schneider; Barbara Bellenberg; Robert Hoepner; Eva-Maria Kolb; Gisa Ellrichmann; Aiden Haghikia; Ralf Gold; Carsten Lukas
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240

Review 10.  Magnetic resonance spectroscopy--a non-invasive method in evaluating focal and diffuse central nervous system disease.

Authors:  C Scheau; E M Preda; G A Popa; A E Ghergus; R A Capsa; I G Lupescu
Journal:  J Med Life       Date:  2012-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.